Page last updated: 2024-08-25

ailanthone and Cancer of Ovary

ailanthone has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barrera, G; Cucci, MA; Damia, G; Dianzani, C; Grattarola, M; Pizzimenti, S; Ricci, F; Roetto, A; Trotta, F1

Other Studies

1 other study(ies) available for ailanthone and Cancer of Ovary

ArticleYear
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
    Free radical biology & medicine, 2020, Volume: 150

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Ovarian Neoplasms; Oxidative Stress; Quassins; Urinary Bladder Neoplasms

2020
chemdatabank.com